The Wilms tumor suppressor gene wt1 is required for development of the spleen  by Herzer, Ute et al.
Brief Communication 837
The Wilms tumor suppressor gene wt1 is required for
development of the spleen
Ute Herzer, Alexander Crocoll, Debra Barton, Norma Howells
and Christoph Englert
The Wilms tumor suppressor gene WT1 (wt1 in mouse) is
unique among tumor suppressors because, in addition to
its involvement in cancer [1,2] and various other diseases
[3–6], it has an essential role in the development of
certain organs. This is revealed by the phenotype of mice
with inactivated wt1 alleles [7]. These animals exhibit a
complete failure of kidney and gonad development as
well as abnormalities of the heart and mesothelial
structures. On a C57BL/6 genetic background, wt1–/–
animals die between day 13.5 (E13.5) and 15.5 (E15.5) of
embryonic development [7]. We report here that crossing
of the wt1 mutation onto different mouse backgrounds
delayed embryonic lethality until birth. In wt1–/– mice on
these different genetic backgrounds, we observed a
dramatic failure of spleen development, in addition to the
well characterized phenotypic abnormalities. The spleen
anlage formed at around E12 to E13 and involuted by the
E15 stage, before the invasion of hematopoietic cells.
The absence of proper spleen development in these
wt1–/– embryos correlated with enhanced apoptosis in
the primordial spleen cells. The expression of hox11, a
gene that also controls development of the spleen [8,9],
was not altered by the inactivation of wt1. In situ
hybridization revealed that the two genes are regulated
independently. These findings demonstrate that the
penetrance of the wt1–/– phenotype depends on the
existence of one or more modifier gene(s) and that wt1
plays a pivotal role in the development of the spleen,
thereby extending its role in organogenesis.
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Results and discussion
The phenotype associated with inactivation of wt1 depends
on the genetic background
The wt1 gene is expressed in the developing kidney, the
stromal cells of the gonads and spleen and the mesothelial
cells that line the heart, diaphragm and peritoneum
[10–12]. All wt1-expressing tissues contain mesoderm-
derived epithelium, and it has therefore been hypothesized
that Wt1 exerts its role by mediating the differentiation
from mesenchyme to epithelium [10]. How Wt1 fulfills this
role in molecular terms is still unclear, but most evidence
suggests that it works as a transcription factor [13]. The tar-
geted inactivation of wt1 leads to a lethal phenotype at
E13.5–E15.5 [7] and, in the C57BL/6 (B6) mouse back-
ground that has been used so far for these experiments, no
viable wt1–/– embryos could be found after day E15.5.
Prompted by the observation that the genetic background
can dramatically influence the phenotypes that result from
gene-targeting experiments [14,15], we bred the wt1
mutation into the mouse strains MF1, Balb/c and C3H.
Genotypic analysis of the offspring from intercrosses of
heterozygous F1 animals revealed that homozygous wt1–/–
animals were born in each case. The mice died immedi-
ately after birth because they could not inflate their lungs.
For all the subsequent typing and phenotypic analyses, we
performed caesarian sections at E18.5 and focused on the
MF1 background. Overall, viable (non-resorbed) wt1–/–
embryos were found with a frequency of approximately
16% (11/67) on a mixed B6 × MF1 background. To dis-
criminate between the influence of the robustness of MF1
mothers and the existence of a modifier gene, we trans-
ferred blastocysts from a pure B6 background as well as
from the mixed MF1 × B6 background into MF1 foster
mothers and analyzed the developing embryos. Whereas
25% of E18.5 embryos (4/12) from the mixed background
were homozygous for the wt1 mutation, no B6 wt1–/–
embryos (0/20) of this age could be found. These results
suggest the existence of one or more gene(s) modifying
the penetrance of the wt1 mutation.
Lack of spleen development in wt1–/– embryos
The longer lifespan of B6 × MF1 wt1–/– embryos enabled
us to examine the wt1–/– phenotype in more detail. It has
recently been reported that wt1 is required for the devel-
opment of the adrenal gland [16]. In agreement with that
observation, the mutant E18.5 embryos on a mixed
MF1 × B6 background lacked adrenal glands. In addi-
tion to the previously described developmental defects
[7], we also found an almost complete absence of the
spleen in wt1–/– animals (Figure 1). Organogenesis of the
spleen involves a reciprocal interaction between the
coelomic epithelium of the dorsal mesogastrium (tissue
connecting the stomach with the body wall) and the
underlying mesenchyme [9,17]. The first morphological
evidence of spleen development is a localized thicken-
ing of the mesogastrium, which also contributes to pan-
creas development. This spleen primordium is visible at
E13.5 of mouse development. The first hematopoietic
cells populate the spleen only after E15.5. 
In order to examine the spleen defect in more detail, we
analyzed histological sections at different stages of devel-
opment. In sections through E13.5 wild-type mice, the
spleen primordium was clearly visible (Figure 2a). In the
mutant embryo, a comparatively smaller spleen pri-
mordium was present and the connection to the prospec-
tive pancreas was shortened (Figure 2b). The stomach
and pancreas, however, developed normally in wt1–/–
embryos. At E15.5, before hematopoietic cells invade the
spleen, a well-developed spleen could be seen in the
wild-type embryos (Figure 2c), whereas only some thick-
ening of the mesogastrium could be observed in wt1–/–
embryos (Figure 2d). This observation demonstrates that
the defect in spleen organogenesis is not due to a lack of
invasion of hematopoietic cells but to a failure of the
stromal cells of the spleen to develop. In E18.5 wt1–/–
embryos, the spleen did not develop any further
(Figure 2f), whereas a normal organ could be observed in
E18.5 wild-type embryos (Figure 2e). 
Wt1 as an anti-apoptotic factor
To analyze whether the failure of proper spleen develop-
ment in wt1–/– animals can be explained by either
impaired proliferation or increased apoptosis, sections of
the developing mesogastrium of wild-type and wt1–/–
embryos were stained with an antibody against the prolif-
erating cell nuclear antigen (PCNA; Figure 3a,b). This
assay revealed the presence of a significant number of
proliferating cells in several organs, including the kidney,
the notochord and the liver. In the developing mesogas-
trium of E13.5 or E14.5 wild-type and wt1–/– embryos,
however, no PCNA-expressing cells could be detected.
These results have been confirmed independently by
bromodeoxyuridine (BrdU) staining (data not shown).
Thus, at this stage of spleen development, proliferation is
not the major determinant of organogenesis. In contrast,
the TUNEL assay showed a significant difference in the
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Figure 1
Whole-tissue preparation of stomach and spleen (sp) from (a) a wild-
type and (b) a wt1–/– mouse embryo at stage E18.5. Although the
stomach is comparable in size and appearance, only a remnant of the
spleen can be observed in the preparation from a wt1–/– embryo. Note
the red/brown color of the mutant spleen, which suggests normal
colonization by hematopoietic cells. Original magnifications: ×10.
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Figure 2
Histology of wild-type and wt1–/– embryos. (a) Transverse section
through an E13.5 wild-type embryo, showing the spleen primordium
(arrowhead) within the mesogastrium, the stomach, the gonad and the
developing kidney. (b) Transverse section through an E13.5 wt1–/–
embryo showing a local thickening of the mesogastrium (arrowhead).
The gonad and kidney are absent. (c) Transverse section through an
E15.5 wild-type embryo. The spleen has increased in size compared
to (a). (d) Transverse section through an E15.5 wt1–/– embryo.
Because of the absence of the kidney, the well-developed pancreas is
located next to the spleen primordium (arrowhead), which has not
developed further compared to (b). (e) Transverse section through an
E18.5 wild-type embryo, showing a normally developed spleen.
(f) Transverse section through an E18.5 wt1–/– embryo, revealing an
almost complete absence of the spleen (arrowhead). Abbreviations:
g, gonad; k, kidney; l, liver; mg, mesogastrium; ms, mesonephros;
p, pancreas; sp, spleen; st, stomach. Original magnifications,
(a,b) ×80, (c,d) ×40, (e,f) ×25.
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amount of apoptosis between E13.5 wild-type and wt1–/–
embryos. Whereas a small percentage of cells underwent
apoptosis in the wild-type animals, a high degree of apop-
tosis was observed in the wt1–/– embryos (Figure 3c,d).
Quantification showed that there was a 4–5-fold increase
in the number of apoptotic cells in the spleen primordium
of wt1–/– embryos compared with wild-type animals
(Figure 3e). A similar difference was also seen at the
E14.5 stage. Thus, the lack of spleen development in
wt1–/– mice correlates with enhanced apoptosis rather than
with a lack of proliferation. 
This situation is reminiscent of kidney development,
during which the absence of wt1 leads to apoptosis in the
metanephric mesenchyme [7]. It is interesting to note in
this context that Wt1 has been shown to have anti-apop-
totic properties because it can inhibit p53-mediated apop-
tosis in osteosarcoma cells [18]. This seems to contradict
the initial characterization of WT1 as a tumor suppressor
gene. However, the recent finding that a chromosomal
translocation that juxtaposes the zinc finger domain of
WT1 to the regulatory domain of the Ewing sarcoma gene
product (EWS) is associated with desmoplastic small
round cell tumors is an additional example of WT1 also
having oncogenic properties [19]. Given the suggested
role of wt1 in the differentiation of mesenchyme to epithe-
lium differentiation, it is conceivable that the anti-apop-
totic properties of wt1 are indirect and that the enhanced
apoptosis in wt1–/– embryos might be a consequence of the
lack of proper differentiation signals.
The wt1 and hox11 genes are regulated independently
during spleen development 
The expression pattern of wt1 (in stromal cells of the
spleen [10,12]) and its mutant phenotype (defective spleen
development) are very similar to those of the hox11 gene
[20]. This homeobox gene has been shown to be required
for organogenesis of the spleen [8,9]. In order to analyze
the relationship between wt1 and hox11, we examined the
expression pattern of hox11 in wild-type and wt1–/– animals
by in situ hybridization. In both wild-type and wt1–/–
embryos, hox11 expression was detected in a ridge of cells
on the dorsal side of the stomach at E13.5 (Figure 4a,b) and
E12.5 (data not shown). Thus, hox11 expression appears to
be unaffected by the wt1 mutation. We then performed the
reciprocal experiment to test whether the expression of wt1
was affected by the hox11 mutation. In hox11–/– animals, wt1
expression could be observed in the developing mesogas-
trium at E12.5 (Figure 4c,d) and E11.5 (data not shown).
These data suggest that, although hox11 and wt1 are coex-
pressed in the spleen primordium and show a similar
phenotype with regard to spleen development, these genes
do not seem to regulate each other. Although wt1 and hox11
appear to act genetically independently, Wt1 and Hox11
proteins could still form a biochemical complex. It will be
challenging to identify the downstream targets of Hox11
and Wt1, in order to learn whether both proteins converge
on the regulation of the same genes that are required for
development of the spleen.
In summary, we have shown that the phenotypic conse-
quences of wt1 inactivation are influenced by modifier
genes and that wt1 is essential for development of the
spleen. Interestingly, all the organs for which Wt1 func-
tion is required share a common feature: they are formed
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Figure 3
Proliferation and apoptosis during early spleen development. (a,b) PCNA
staining of the mesogastrium from (a) a wild-type and (b) a wt1–/– E13.5
embryo. No PCNA-expressing cells could be detected in either. The
staining in the wild-type mesogastrium is not nuclear and is therefore
non-specific. As a positive control, liver tissue from the same slides is
shown (insets). (c,d) Apoptosis in the mesogastrium of (c) a
wild-type and (d) a wt1–/– E13.5 embryo as determined by the TUNEL
method. Apoptotic cells are marked by arrowheads. Original
magnifications, ×20 (insets, ×40). (e) Quantification of apoptosis in wild-
type and wt1–/– embryos at E13.5 and E14.5. The values were obtained
by dividing the numbers of apoptotic cells by the area of the respective
mesogastrium. The mean ± standard deviation of values from four
different animals (or three E14.5 wt1–/– animals) are shown; at least four
sections were counted from each animal.
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by interactions between epithelial and mesenchymal com-
ponents. Originally, the role of Wt1 has been viewed as
mediation of the ‘one-way’ transition from a mesenchymal
cell to a well-differentiated epithelial cell. More recently,
however, Wt1 has been suggested to enable cells to flip
between epithelial and mesenchymal states [16].
Although the precise molecular mechanism of Wt1 func-
tion is still unclear, the data presented here contribute to
the notion that Wt1 mediates a process that is fundamen-
tal to organogenesis.
Materials and methods
Mouse strains
A wt1+/– and a hox11–/– breeding pair were obtained from The
Jackson Laboratory (Bar Harbor, USA). The former was genotyped
according to the protocol provided. The hox11 mutant animals were
genotyped by PCR as well as Southern-blotting analysis as described
[S1]. The inbred strains BALB/cOlaHsd, C3H/HeNHsd and
C57BL/6JOlaHsd as well as the outbred strain HsdOla:MF1 are main-
tained as breeding colonies in-house.
Supplementary material
Supplementary material including additional methodological details
of immunohistochemistry and in situ hybridization is available at
http://current-biology.com/supmat/supmatin.htm.
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Figure 4
Independent regulation of hox11 and wt1. Whole-mount in situ
hybridizations of (a) wild-type and (b) wt1–/– stomach and
mesogastrium of stage E13.5 embryos with a hox11-specific probe.
Staining of the mesogastrium on the dorsal side of the stomach can be
observed in both. Whole-mount in situ hybridizations of (c) a wild-type
and (d) a hox11–/– stomach and mesogastrium of stage E12.5 embryos
with a wt1-specific probe. The expression pattern of the wt1 gene is not
altered by the hox11 mutation. Original magnifications, ×25.
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Supplementary materials and methods
Mouse strains
A wt1+/– and a hox11–/– breeding pair were obtained from The Jackson
Laboratory (Bar Harbor, USA). The former was genotyped according to
the protocol provided. The hox11 mutant animals were genotyped by
PCR as well as Southern-blotting analysis as described [S1]. The
inbred strains BALB/cOlaHsd, C3H/HeNHsd and C57BL/6JOlaHsd
as well as the outbred strain HsdOla:MF1 are maintained as breeding
colonies in-house.
Immunohistochemistry
Embryos were fixed in 10% formalin and routinely processed for paraf-
fin embedding. Sections 6 µm thick were cut from paraffin blocks,
deparaffinized and hydrated before immunostaining. PCNA staining
was started with an incubation in 2 N HCl for 10 min followed by
several blocking steps to prevent non-specific staining in 0.3% hydro-
gen peroxide, avidin, biotin, 10% normal horse serum and 0.5% mouse
serum. PCNA antibody (DAKO) was applied in a 1:100 dilution fol-
lowed by a biotinylated horse anti-mouse (1:50) secondary antibody.
An avidin-linked peroxidase enzyme was used for detection using
3-amino-9-ethylcarbazole as a substrate. The sections were counter-
stained with hematoxylin and mounted under coverslips with aqueous
mounting medium. Apoptotic nuclei were stained using the Apoptag kit
(Oncor) following the manufacturer’s protocol. 
In situ hybridization
A hox11-specific in situ hybridization probe was generated by PCR
amplification of a genomic fragment using the upstream primer
5′-AGAGGAACGTGAGGCCGAGA-3′ and the downstream primer
5′-GGATCCCAGAAGCCTTCCGG-3′ [S1] and subsequent TA-cloning
into the pGEM-T vector (Promega). To generate the antisense and sense
control probes, the recombinant plasmid was linearized with ApaI or
BstXI and used as a template for in vitro transcription with SP6 or T7
RNA polymerase. Antisense and sense control probes specific for wt1
were generated by digestion of a pBluescript II SK plasmid containing
codons 98 to 449 of wt1 with EcoRI or HindIII and in vitro transcription
with T7 or T3 RNA polymerase. Procedures for whole-mount in situ
hybridization were followed as described elsewhere [S2] with the follow-
ing modifications. Riboprobes were precipitated with LiCl, washed and
resuspended in DEPC-treated water. Abdominal organs were dissected
and fixed in 4% paraformaldehyde in PBS at 4°C overnight. The organs
were then treated with proteinase K (4.5 µg/ml) in PBST (PBS + 0.1%
Tween-20) for 4 min at room temperature. The final washing steps after
prehybridization and hybridization of the tissues were done in maleic acid
buffer (100 mM maleic acid pH 7.5, 150 mM NaCl) at room temperature
(2 × 10 min), at 70°C (2 × 30 min), and finally in PBS at room tempera-
ture (2 × 10 min). Tissues were stained in BM purple substrate (Roche)
and signals became visible after 3.5 h (wt1) or 5 h (hox11). The speci-
ficity of the probes was confirmed using the respective sense probes,
which led to the detection of no specific signals.
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